Comparative analysis of the risk-handling procedures for Gene technology applications in medical and plant science

Abstract In this paper we analyse how the risks associated with research on transgenic plants are regulated in Sweden. The paper outlines the way in which pilot projects in the plant sciences are overseen in Sweden, and discusses the international and national background to the current regulatory system. The historical, and hitherto unexplored, reasons for the evolution of current administrative and legislative procedures in plant science are of particular interest. Specifically, we discuss similarities and differences in the regulation of medicine and plant science, and we examine the tendency towards dichotomizing risk — focusing on social/ethical risks in medicine and biological risks in plant science. The context of this article is the Synpraxia research project, an inter-disciplinary program combining expertise in sciences and the humanities.
Keywords No keywords specified (fix it)
Categories
Options
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
 
Download options
PhilPapers Archive


Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 5,679
External links
  • Through your library Configure

    Similar books and articles
    Carl F. Cranor (1988). Some Public Policy Problems with the Science of Carcinogen Risk Assessment. PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1988:467 - 488.

    Analytics

    Monthly downloads

    Added to index

    2009-01-28

    Total downloads

    3 ( #201,930 of 549,087 )

    Recent downloads (6 months)

    0

    How can I increase my downloads?


    My notes
    Sign in to use this feature


    Discussion
    Start a new thread
    Order:
    There  are no threads in this forum
    Nothing in this forum yet.

    Other forums